Taiwan FDA registration 25c03aaa6fa56fb240cd2df97b5f2a26

“HippoScreen” Stress EEG Assessment System

TW: “宏智生醫”憂可視腦波壓力評估系統
Taiwan flagTaiwan·Risk Class 2·MD·Hongzhi Biomedical Technology Co., Ltd·Registered Oct 13, 2023 – Oct 13, 2028Active
Registration details
Analysis ID
25c03aaa6fa56fb240cd2df97b5f2a26
License Form
Ministry of Health Medical Device Manufacturing No. 008104
Company information
Manufacturer Country
Taiwan, Province of China
Product details
Intended Use
The software medical device (SaMD) to assist in the diagnosis of suspected depression is used to analyze the time-domain and frequency-domain characteristics of the brainwave data measured by the brainwave smograph, and generate a quantitative index (SEA Index), which is provided to medical professionals as a diagnostic reference. This system is only used by medical professionals as a reference for clinical assistance in diagnosing suspected depression, and cannot replace the judgment of medical professionals.
Product Type (Level 1)
K Neuroscience
Product Type (Level 2)
K1400 brainwave scanner
Import Information
Produced in Taiwan, China
Dates and status
Registration Date
Oct 13, 2023
Expiry Date
Oct 13, 2028
About this record

Access comprehensive regulatory information for “HippoScreen” Stress EEG Assessment System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 25c03aaa6fa56fb240cd2df97b5f2a26 and manufactured by Hongzhi Biomedical Technology Co., Ltd. The authorized representative in Taiwan is Hongzhi Biomedical Technology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices